Mice show brain, behavior changes weeks after oxytocin treatment
Intranasal oxytocin may spur new neuron growth and changes in social behavior after a few weeks.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
Intranasal oxytocin may spur new neuron growth and changes in social behavior after a few weeks.
Mice that model 22q11.2 deletion syndrome lack social memory, but that trait can be reversed using a drug that targets the flow of potassium ions in neurons.
This is part 2 of Owen’s story. It tracks his early progress in treatment for autism. Part 1 described his difficult path to a diagnosis.
Studies of autism treatments rarely report adverse events, and the scientists involved often fail to disclose their conflicts of interest.
An interactive assessment allows clinicians and researchers to evaluate an autistic child’s use of language in everyday social situations.
A gene-editing treatment shows long-lasting effects in a mouse model of Angelman syndrome, a genetic condition related to autism.
All five participants in a clinical trial of a gene therapy for Angelman syndrome experienced leg weakness, leading sponsors to pause the study.
Rapid growth and inadequate standards in the ‘applied behavior analysis’ industry may put vulnerable children in the hands of poorly prepared technicians.
Girls with autism tend to start puberty earlier than their peers do, which may intensify their social difficulties and put them at an increased risk for bullying and mental health conditions such as depression.
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.